

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.99004380 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.99004380 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94565329 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.16290740 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.08316590 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97648881 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 3.79986043 |
| 8 | negative T cell selection (GO:0043383) | 3.76900273 |
| 9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.76441014 |
| 10 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.69988428 |
| 11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.68385070 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.58919659 |
| 13 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.58396137 |
| 14 | response to interleukin-15 (GO:0070672) | 3.51544724 |
| 15 | interferon-gamma production (GO:0032609) | 3.50865396 |
| 16 | negative thymic T cell selection (GO:0045060) | 3.50468459 |
| 17 | nuclear pore complex assembly (GO:0051292) | 3.49208678 |
| 18 | positive regulation of isotype switching (GO:0045830) | 3.36198289 |
| 19 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.17859678 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.15607970 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.15607970 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.15607970 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.15607970 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.15607970 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.15607970 |
| 26 | tolerance induction (GO:0002507) | 3.14642214 |
| 27 | natural killer cell differentiation (GO:0001779) | 3.14069777 |
| 28 | myeloid dendritic cell differentiation (GO:0043011) | 3.13414136 |
| 29 | myeloid dendritic cell activation (GO:0001773) | 3.07999946 |
| 30 | T cell selection (GO:0045058) | 3.06663364 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 3.06501400 |
| 32 | thymic T cell selection (GO:0045061) | 3.00867379 |
| 33 | stress fiber assembly (GO:0043149) | 3.00797075 |
| 34 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.96867494 |
| 35 | positive regulation of B cell mediated immunity (GO:0002714) | 2.96867494 |
| 36 | nuclear pore organization (GO:0006999) | 2.96246409 |
| 37 | negative regulation of cell killing (GO:0031342) | 2.96103151 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96103151 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93716453 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 2.93497199 |
| 41 | positive thymic T cell selection (GO:0045059) | 2.92851248 |
| 42 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.90801055 |
| 43 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90555824 |
| 44 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89146426 |
| 45 | leukocyte aggregation (GO:0070486) | 2.86078612 |
| 46 | adhesion of symbiont to host cell (GO:0044650) | 2.85649021 |
| 47 | virion attachment to host cell (GO:0019062) | 2.85649021 |
| 48 | response to peptidoglycan (GO:0032494) | 2.85363168 |
| 49 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.84358886 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84122608 |
| 51 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.83990770 |
| 52 | positive regulation of tolerance induction (GO:0002645) | 2.81956129 |
| 53 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80805818 |
| 54 | T cell migration (GO:0072678) | 2.80054580 |
| 55 | cellular response to interleukin-15 (GO:0071350) | 2.78914787 |
| 56 | regulation of tolerance induction (GO:0002643) | 2.77702007 |
| 57 | regulation of type 2 immune response (GO:0002828) | 2.76034578 |
| 58 | positive regulation of interleukin-2 production (GO:0032743) | 2.75305520 |
| 59 | response to interferon-alpha (GO:0035455) | 2.72989847 |
| 60 | natural killer cell activation (GO:0030101) | 2.72942181 |
| 61 | collagen fibril organization (GO:0030199) | 2.72870259 |
| 62 | response to laminar fluid shear stress (GO:0034616) | 2.72497488 |
| 63 | fibril organization (GO:0097435) | 2.72129934 |
| 64 | negative regulation of type 2 immune response (GO:0002829) | 2.72117675 |
| 65 | pore complex assembly (GO:0046931) | 2.71426005 |
| 66 | response to type I interferon (GO:0034340) | 2.70589482 |
| 67 | positive T cell selection (GO:0043368) | 2.70575037 |
| 68 | protein heterotrimerization (GO:0070208) | 2.70564273 |
| 69 | definitive hemopoiesis (GO:0060216) | 2.69612414 |
| 70 | positive regulation of DNA recombination (GO:0045911) | 2.69027017 |
| 71 | mitotic sister chromatid cohesion (GO:0007064) | 2.68684725 |
| 72 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68653803 |
| 73 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.68584943 |
| 74 | detection of molecule of bacterial origin (GO:0032490) | 2.68499984 |
| 75 | protein localization to endosome (GO:0036010) | 2.67629258 |
| 76 | response to muramyl dipeptide (GO:0032495) | 2.67051416 |
| 77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.66371509 |
| 78 | skin morphogenesis (GO:0043589) | 2.66261329 |
| 79 | cellular response to type I interferon (GO:0071357) | 2.65929668 |
| 80 | type I interferon signaling pathway (GO:0060337) | 2.65929668 |
| 81 | T cell costimulation (GO:0031295) | 2.64720501 |
| 82 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.64664773 |
| 83 | regulation of extracellular matrix disassembly (GO:0010715) | 2.64604547 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.64559975 |
| 85 | T cell homeostasis (GO:0043029) | 2.63876088 |
| 86 | cellular response to interferon-alpha (GO:0035457) | 2.62414544 |
| 87 | regulation of natural killer cell differentiation (GO:0032823) | 2.61413954 |
| 88 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.57970648 |
| 89 | lymphocyte costimulation (GO:0031294) | 2.57842332 |
| 90 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57277090 |
| 91 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.57194545 |
| 92 | endothelial tube morphogenesis (GO:0061154) | 2.56654279 |
| 93 | morphogenesis of an endothelium (GO:0003159) | 2.56654279 |
| 94 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56580589 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.56431722 |
| 96 | alpha-beta T cell activation (GO:0046631) | 2.56312082 |
| 97 | regulation of interferon-alpha production (GO:0032647) | 2.56198796 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.55035611 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.55035611 |
| 100 | barbed-end actin filament capping (GO:0051016) | 2.53773094 |
| 101 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.52568681 |
| 102 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.52411598 |
| 103 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.52411598 |
| 104 | positive regulation of type 2 immune response (GO:0002830) | 2.51761312 |
| 105 | positive regulation of B cell differentiation (GO:0045579) | 2.51721728 |
| 106 | T cell receptor signaling pathway (GO:0050852) | 2.50039906 |
| 107 | regulation of regulatory T cell differentiation (GO:0045589) | 2.49986866 |
| 108 | positive regulation of histone deacetylation (GO:0031065) | 2.47545982 |
| 109 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.46435655 |
| 110 | lymphocyte chemotaxis (GO:0048247) | 2.46414503 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 2.46115555 |
| 112 | negative regulation of interleukin-12 production (GO:0032695) | 2.46040967 |
| 113 | positive regulation of macrophage differentiation (GO:0045651) | 2.45768192 |
| 114 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.44347767 |
| 115 | pinocytosis (GO:0006907) | 2.44249786 |
| 116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.44129363 |
| 117 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.43633699 |
| 118 | positive regulation of interferon-alpha production (GO:0032727) | 2.43054704 |
| 119 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.42876163 |
| 120 | T cell apoptotic process (GO:0070231) | 2.42713721 |
| 121 | activated T cell proliferation (GO:0050798) | 2.42354533 |
| 122 | adhesion of symbiont to host (GO:0044406) | 2.42220298 |
| 123 | regulation of B cell differentiation (GO:0045577) | 2.41676404 |
| 124 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.41660369 |
| 125 | mast cell activation (GO:0045576) | 2.41296023 |
| 126 | T cell proliferation (GO:0042098) | 2.41106571 |
| 127 | germ cell migration (GO:0008354) | 2.40232438 |
| 128 | alpha-beta T cell differentiation (GO:0046632) | 2.40205137 |
| 129 | detection of other organism (GO:0098543) | 2.39994753 |
| 130 | cell migration involved in heart development (GO:0060973) | 2.39938099 |
| 131 | leukocyte cell-cell adhesion (GO:0007159) | 2.39677959 |
| 132 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.39280525 |
| 133 | response to protozoan (GO:0001562) | 2.38210255 |
| 134 | germinal center formation (GO:0002467) | 2.38144332 |
| 135 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.36975300 |
| 136 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.36871101 |
| 137 | positive regulation of humoral immune response (GO:0002922) | 2.36859641 |
| 138 | DNA unwinding involved in DNA replication (GO:0006268) | 2.36646957 |
| 139 | positive regulation of interleukin-17 production (GO:0032740) | 2.36465717 |
| 140 | negative regulation of viral genome replication (GO:0045071) | 2.35866939 |
| 141 | substrate-dependent cell migration (GO:0006929) | 2.35810381 |
| 142 | extracellular matrix assembly (GO:0085029) | 2.35190222 |
| 143 | negative regulation of interleukin-6 production (GO:0032715) | 2.34834960 |
| 144 | cellular extravasation (GO:0045123) | 2.34499745 |
| 145 | detection of external biotic stimulus (GO:0098581) | 2.34445652 |
| 146 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.34303767 |
| 147 | regulation of interleukin-2 production (GO:0032663) | 2.34268042 |
| 148 | regulation of podosome assembly (GO:0071801) | 2.34063950 |
| 149 | cellular response to virus (GO:0098586) | 2.34032232 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.33912394 |
| 151 | defense response to protozoan (GO:0042832) | 2.33721335 |
| 152 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.33616251 |
| 153 | embryonic process involved in female pregnancy (GO:0060136) | 2.33139301 |
| 154 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.33134345 |
| 155 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.32715640 |
| 156 | regulation of isotype switching (GO:0045191) | 2.32635124 |
| 157 | lymphocyte homeostasis (GO:0002260) | 2.32561200 |
| 158 | T cell differentiation (GO:0030217) | 2.31481745 |
| 159 | regulation of response to interferon-gamma (GO:0060330) | 2.31041165 |
| 160 | lymph node development (GO:0048535) | 2.30831741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.60105275 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.76980001 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.50227658 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.23502843 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.78261093 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.43131048 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.16749164 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.14153557 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.11574601 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.81679169 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79962633 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71212207 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.71068227 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.66123795 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.64298499 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.61356055 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.57721071 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.55435616 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.53611960 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.45448360 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.34904144 |
| 22 | * MYB_26560356_Chip-Seq_TH1_Human | 2.34324418 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.31155765 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23957067 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22987466 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.21433568 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16282040 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.09431210 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07184885 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04703095 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04678788 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03838545 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00208972 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.94341682 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89104946 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87549098 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85859812 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85198548 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.78395325 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76991196 |
| 41 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74403778 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73641660 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.72997732 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.68609112 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66035128 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.62330647 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59548408 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56744761 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55904758 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53291560 |
| 51 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.51835650 |
| 52 | * MAF_26560356_Chip-Seq_TH2_Human | 1.47228109 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41107894 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38814992 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35873008 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35050895 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29203356 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27658957 |
| 59 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.25483092 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23202244 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22987004 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22235038 |
| 63 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21780629 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19627161 |
| 65 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18036238 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17467488 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17102460 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16995765 |
| 69 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15114667 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14806814 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13840667 |
| 72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11732733 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10838720 |
| 74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10582849 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10145936 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09202975 |
| 77 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.09041246 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08789754 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08780179 |
| 80 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07278783 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06782100 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05297842 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03182768 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03169554 |
| 85 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03149261 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02116601 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02112938 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02045441 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01555166 |
| 90 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00677159 |
| 91 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00677159 |
| 92 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00491674 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99769442 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98303485 |
| 95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98265214 |
| 96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98265214 |
| 97 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97175536 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97173396 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96379052 |
| 100 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95700940 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94909405 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94310182 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94001045 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92882294 |
| 105 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91660187 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90613884 |
| 107 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.90593808 |
| 108 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90394374 |
| 109 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90168412 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89582333 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89228097 |
| 112 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.88297321 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87190208 |
| 114 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.86936153 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86731441 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86551176 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86245447 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85939529 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85139968 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.84574962 |
| 121 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83258935 |
| 122 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82755759 |
| 123 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82207792 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81911828 |
| 125 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.81221754 |
| 126 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78174411 |
| 127 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78041576 |
| 128 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77596437 |
| 129 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76690944 |
| 130 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76372678 |
| 131 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.74784372 |
| 132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.73835128 |
| 133 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.73389247 |
| 134 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.72234242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.00387822 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.87543691 |
| 3 | MP0000685_abnormal_immune_system | 2.81706389 |
| 4 | MP0005671_abnormal_response_to | 2.76162559 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.64311324 |
| 6 | MP0003436_decreased_susceptibility_to | 2.63106874 |
| 7 | MP0009278_abnormal_bone_marrow | 2.46045160 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.44385013 |
| 9 | MP0001790_abnormal_immune_system | 2.40510480 |
| 10 | MP0005387_immune_system_phenotype | 2.40510480 |
| 11 | MP0009785_altered_susceptibility_to | 2.38334944 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.38289070 |
| 13 | MP0004808_abnormal_hematopoietic_stem | 2.36152956 |
| 14 | MP0001800_abnormal_humoral_immune | 2.25725170 |
| 15 | MP0005257_abnormal_intraocular_pressure | 2.25519311 |
| 16 | MP0005275_abnormal_skin_tensile | 2.24773991 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.23829027 |
| 18 | MP0001545_abnormal_hematopoietic_system | 2.12781674 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.12781674 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.12734131 |
| 21 | MP0003303_peritoneal_inflammation | 2.12451507 |
| 22 | MP0005503_abnormal_tendon_morphology | 2.12054044 |
| 23 | MP0002405_respiratory_system_inflammati | 2.11882621 |
| 24 | MP0002006_tumorigenesis | 2.11411265 |
| 25 | MP0002723_abnormal_immune_serum | 2.08204023 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.05578677 |
| 27 | MP0002398_abnormal_bone_marrow | 2.05210418 |
| 28 | MP0001542_abnormal_bone_strength | 2.05163183 |
| 29 | MP0001819_abnormal_immune_cell | 2.04421417 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 2.03093364 |
| 31 | MP0005171_absent_coat_pigmentation | 1.97212817 |
| 32 | MP0005025_abnormal_response_to | 1.94101440 |
| 33 | MP0003724_increased_susceptibility_to | 1.93119077 |
| 34 | MP0002933_joint_inflammation | 1.90624185 |
| 35 | MP0004947_skin_inflammation | 1.89449652 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.86836946 |
| 37 | MP0001873_stomach_inflammation | 1.85529955 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.83459821 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.82607128 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.81027123 |
| 41 | MP0002419_abnormal_innate_immunity | 1.78715563 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.77264565 |
| 43 | MP0000716_abnormal_immune_system | 1.73636760 |
| 44 | MP0003448_altered_tumor_morphology | 1.73494303 |
| 45 | MP0002722_abnormal_immune_system | 1.69268100 |
| 46 | MP0004510_myositis | 1.66500917 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.65827519 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.59715460 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.52975283 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.52778258 |
| 51 | MP0001853_heart_inflammation | 1.52484030 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.51463529 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.51243679 |
| 54 | MP0002877_abnormal_melanocyte_morpholog | 1.50891174 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.49778100 |
| 56 | MP0006082_CNS_inflammation | 1.48733053 |
| 57 | MP0002429_abnormal_blood_cell | 1.48120796 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.46126881 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.46056158 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.44077859 |
| 61 | MP0000858_altered_metastatic_potential | 1.39525515 |
| 62 | MP0005164_abnormal_response_to | 1.37692322 |
| 63 | MP0010307_abnormal_tumor_latency | 1.36060148 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.35376423 |
| 65 | MP0003091_abnormal_cell_migration | 1.35247480 |
| 66 | MP0010094_abnormal_chromosome_stability | 1.32385426 |
| 67 | MP0003279_aneurysm | 1.31691781 |
| 68 | MP0000490_abnormal_crypts_of | 1.31622217 |
| 69 | MP0002254_reproductive_system_inflammat | 1.31515752 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 1.30495063 |
| 71 | MP0005023_abnormal_wound_healing | 1.30435273 |
| 72 | MP0004883_abnormal_blood_vessel | 1.27849124 |
| 73 | MP0003866_abnormal_defecation | 1.27399458 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.23598389 |
| 75 | MP0001958_emphysema | 1.23072944 |
| 76 | MP0009840_abnormal_foam_cell | 1.21802375 |
| 77 | MP0001348_abnormal_lacrimal_gland | 1.17151379 |
| 78 | MP0000371_diluted_coat_color | 1.11504793 |
| 79 | MP0006054_spinal_hemorrhage | 1.10858128 |
| 80 | MP0004272_abnormal_basement_membrane | 1.10018112 |
| 81 | MP0008057_abnormal_DNA_replication | 1.09923165 |
| 82 | MP0008007_abnormal_cellular_replicative | 1.09706965 |
| 83 | MP0002060_abnormal_skin_morphology | 1.07454150 |
| 84 | MP0002019_abnormal_tumor_incidence | 1.04149555 |
| 85 | MP0005174_abnormal_tail_pigmentation | 1.02141184 |
| 86 | MP0003075_altered_response_to | 1.01885180 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 1.00499624 |
| 88 | MP0003077_abnormal_cell_cycle | 1.00038693 |
| 89 | MP0005451_abnormal_body_composition | 0.99394011 |
| 90 | MP0001851_eye_inflammation | 0.98458690 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.97870185 |
| 92 | MP0008004_abnormal_stomach_pH | 0.97069059 |
| 93 | MP0008260_abnormal_autophagy | 0.96471907 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.95866548 |
| 95 | MP0004381_abnormal_hair_follicle | 0.95658394 |
| 96 | MP0009764_decreased_sensitivity_to | 0.91768071 |
| 97 | MP0000733_abnormal_muscle_development | 0.91446731 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.91116944 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.90620145 |
| 100 | MP0003045_fibrosis | 0.89464578 |
| 101 | MP0005390_skeleton_phenotype | 0.88287525 |
| 102 | MP0005410_abnormal_fertilization | 0.87604615 |
| 103 | MP0005595_abnormal_vascular_smooth | 0.86059487 |
| 104 | MP0008469_abnormal_protein_level | 0.83569459 |
| 105 | MP0003795_abnormal_bone_structure | 0.82583238 |
| 106 | MP0001915_intracranial_hemorrhage | 0.82494634 |
| 107 | MP0003111_abnormal_nucleus_morphology | 0.82262955 |
| 108 | MP0002009_preneoplasia | 0.81145319 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.80542351 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.79338570 |
| 111 | MP0000372_irregular_coat_pigmentation | 0.79323964 |
| 112 | MP0000604_amyloidosis | 0.78122795 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.77976466 |
| 114 | MP0000569_abnormal_digit_pigmentation | 0.77887612 |
| 115 | MP0001849_ear_inflammation | 0.77684062 |
| 116 | MP0000343_altered_response_to | 0.77336982 |
| 117 | MP0000249_abnormal_blood_vessel | 0.76504530 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.75509280 |
| 119 | MP0005165_increased_susceptibility_to | 0.72944392 |
| 120 | MP0005409_darkened_coat_color | 0.72740449 |
| 121 | MP0005166_decreased_susceptibility_to | 0.72591071 |
| 122 | MP0002086_abnormal_extraembryonic_tissu | 0.72040500 |
| 123 | MP0002132_abnormal_respiratory_system | 0.71478386 |
| 124 | MP0003693_abnormal_embryo_hatching | 0.71400632 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.71058769 |
| 126 | MP0004197_abnormal_fetal_growth/weight/ | 0.70286547 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.67326415 |
| 128 | MP0004957_abnormal_blastocyst_morpholog | 0.65850715 |
| 129 | MP0002925_abnormal_cardiovascular_devel | 0.63864916 |
| 130 | MP0002282_abnormal_trachea_morphology | 0.63402924 |
| 131 | MP0001243_abnormal_dermal_layer | 0.63183856 |
| 132 | MP0003828_pulmonary_edema | 0.62400654 |
| 133 | MP0010368_abnormal_lymphatic_system | 0.62319067 |
| 134 | MP0002113_abnormal_skeleton_development | 0.61648986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.49842961 |
| 2 | T lymphocytopenia (HP:0005403) | 4.10598929 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.01645618 |
| 4 | Peritonitis (HP:0002586) | 3.74662006 |
| 5 | Nasal polyposis (HP:0100582) | 3.60726805 |
| 6 | Recurrent viral infections (HP:0004429) | 3.53285018 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49758284 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.34521488 |
| 9 | Increased density of long bones (HP:0006392) | 3.33335530 |
| 10 | Abnormality of the nasal mucosa (HP:0000433) | 3.31425967 |
| 11 | Absent frontal sinuses (HP:0002688) | 3.30579643 |
| 12 | Genu recurvatum (HP:0002816) | 3.30539412 |
| 13 | Myositis (HP:0100614) | 3.25124532 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.18889672 |
| 15 | Abnormality of T cells (HP:0002843) | 3.08132790 |
| 16 | Chronic otitis media (HP:0000389) | 3.05131099 |
| 17 | Vascular tortuosity (HP:0004948) | 2.99763031 |
| 18 | Eczematoid dermatitis (HP:0000976) | 2.98354486 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 2.83994838 |
| 20 | Soft skin (HP:0000977) | 2.74219967 |
| 21 | Thrombocytosis (HP:0001894) | 2.73872248 |
| 22 | Abnormality of the fingertips (HP:0001211) | 2.70825008 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.66380959 |
| 24 | Persistence of primary teeth (HP:0006335) | 2.65374422 |
| 25 | Aortic regurgitation (HP:0001659) | 2.64068794 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.63588829 |
| 27 | Blue sclerae (HP:0000592) | 2.59844889 |
| 28 | Stomatitis (HP:0010280) | 2.59707223 |
| 29 | Joint stiffness (HP:0001387) | 2.59673348 |
| 30 | Orchitis (HP:0100796) | 2.58251913 |
| 31 | IgM deficiency (HP:0002850) | 2.57766480 |
| 32 | B lymphocytopenia (HP:0010976) | 2.57486252 |
| 33 | Abnormality of B cell number (HP:0010975) | 2.57486252 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.55803685 |
| 35 | Optic neuritis (HP:0100653) | 2.55803685 |
| 36 | Arterial tortuosity (HP:0005116) | 2.55077108 |
| 37 | Follicular hyperkeratosis (HP:0007502) | 2.52021283 |
| 38 | Bladder diverticulum (HP:0000015) | 2.51301763 |
| 39 | Mitral regurgitation (HP:0001653) | 2.50381512 |
| 40 | Wormian bones (HP:0002645) | 2.49999282 |
| 41 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.49881454 |
| 42 | Vertebral compression fractures (HP:0002953) | 2.49638552 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.44012353 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41553880 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41553880 |
| 46 | Abnormal platelet volume (HP:0011876) | 2.41472152 |
| 47 | Slender build (HP:0001533) | 2.40439801 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.37690075 |
| 49 | Epiphyseal dysplasia (HP:0002656) | 2.37615776 |
| 50 | Spinal cord lesions (HP:0100561) | 2.36745515 |
| 51 | Syringomyelia (HP:0003396) | 2.36745515 |
| 52 | Type 1 muscle fiber predominance (HP:0003803) | 2.32451162 |
| 53 | Fragile skin (HP:0001030) | 2.31885764 |
| 54 | Acute myeloid leukemia (HP:0004808) | 2.31869189 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.31361647 |
| 56 | Ocular albinism (HP:0001107) | 2.30365789 |
| 57 | Osteolytic defects of the hand bones (HP:0009699) | 2.29997217 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29997217 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.28814777 |
| 60 | Broad metatarsal (HP:0001783) | 2.27989526 |
| 61 | Shallow orbits (HP:0000586) | 2.27873943 |
| 62 | Atrophic scars (HP:0001075) | 2.27336095 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.26785691 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.26785691 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.26785691 |
| 66 | Arterial thrombosis (HP:0004420) | 2.25688795 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.25028111 |
| 68 | Eosinophilia (HP:0001880) | 2.23769813 |
| 69 | Severe combined immunodeficiency (HP:0004430) | 2.22137211 |
| 70 | Aneurysm (HP:0002617) | 2.21729382 |
| 71 | IgA deficiency (HP:0002720) | 2.21314940 |
| 72 | Thin bony cortex (HP:0002753) | 2.20294519 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.19958869 |
| 74 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19728964 |
| 75 | Spinal rigidity (HP:0003306) | 2.18537937 |
| 76 | Autoimmune thrombocytopenia (HP:0001973) | 2.17540050 |
| 77 | Increased mean platelet volume (HP:0011877) | 2.16752108 |
| 78 | Cervical subluxation (HP:0003308) | 2.15620195 |
| 79 | Entropion (HP:0000621) | 2.15388249 |
| 80 | Emphysema (HP:0002097) | 2.14532935 |
| 81 | Cellulitis (HP:0100658) | 2.14140027 |
| 82 | Biconcave vertebral bodies (HP:0004586) | 2.13061521 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.12636112 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 2.12617052 |
| 85 | Cerebral aneurysm (HP:0004944) | 2.11770068 |
| 86 | Leukocytosis (HP:0001974) | 2.11204236 |
| 87 | Joint laxity (HP:0001388) | 2.11179471 |
| 88 | Cutaneous melanoma (HP:0012056) | 2.09131092 |
| 89 | Inflammation of the large intestine (HP:0002037) | 2.08193189 |
| 90 | Combined immunodeficiency (HP:0005387) | 2.07618731 |
| 91 | Thyroiditis (HP:0100646) | 2.07413720 |
| 92 | Aortic aneurysm (HP:0004942) | 2.06938795 |
| 93 | Aortic valve stenosis (HP:0001650) | 2.05978961 |
| 94 | Bronchitis (HP:0012387) | 2.05296862 |
| 95 | Vasculitis (HP:0002633) | 2.02573930 |
| 96 | Recurrent bacterial skin infections (HP:0005406) | 2.02076885 |
| 97 | Bicuspid aortic valve (HP:0001647) | 2.01232754 |
| 98 | Radial bowing (HP:0002986) | 2.00038925 |
| 99 | Protrusio acetabuli (HP:0003179) | 1.97489160 |
| 100 | Neonatal short-limb short stature (HP:0008921) | 1.97224244 |
| 101 | Petechiae (HP:0000967) | 1.96965335 |
| 102 | Ovoid vertebral bodies (HP:0003300) | 1.96935717 |
| 103 | Abnormality of dentin (HP:0010299) | 1.95246962 |
| 104 | Hypoplasia of the iris (HP:0007676) | 1.95009745 |
| 105 | Keratoconjunctivitis (HP:0001096) | 1.94605620 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94350312 |
| 107 | Mucopolysacchariduria (HP:0008155) | 1.94350312 |
| 108 | Abnormality of eosinophils (HP:0001879) | 1.94211530 |
| 109 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94163969 |
| 110 | Hypergammaglobulinemia (HP:0010702) | 1.94097272 |
| 111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93996011 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93996011 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93996011 |
| 114 | Meningitis (HP:0001287) | 1.93952275 |
| 115 | IgG deficiency (HP:0004315) | 1.92882384 |
| 116 | Abnormality of the frontal sinuses (HP:0002687) | 1.91387424 |
| 117 | Pulmonary infiltrates (HP:0002113) | 1.91029190 |
| 118 | Increased connective tissue (HP:0009025) | 1.90561165 |
| 119 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.88685641 |
| 120 | Dilatation of the ascending aorta (HP:0005111) | 1.88498737 |
| 121 | Hemoptysis (HP:0002105) | 1.87869721 |
| 122 | Papilledema (HP:0001085) | 1.86991147 |
| 123 | Hyperextensible skin (HP:0000974) | 1.86978968 |
| 124 | Bowel diverticulosis (HP:0005222) | 1.86279419 |
| 125 | Gingivitis (HP:0000230) | 1.85820030 |
| 126 | Increased IgM level (HP:0003496) | 1.85688360 |
| 127 | Spondylolisthesis (HP:0003302) | 1.85161957 |
| 128 | Dislocated radial head (HP:0003083) | 1.85123893 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 1.85026738 |
| 130 | Overgrowth (HP:0001548) | 1.83179478 |
| 131 | Mitral stenosis (HP:0001718) | 1.80498317 |
| 132 | Hematochezia (HP:0002573) | 1.80404819 |
| 133 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.79387797 |
| 134 | Mitral valve prolapse (HP:0001634) | 1.79291095 |
| 135 | Granulocytopenia (HP:0001913) | 1.79072902 |
| 136 | Prolonged bleeding time (HP:0003010) | 1.78863638 |
| 137 | Keratoconjunctivitis sicca (HP:0001097) | 1.78374887 |
| 138 | Poikiloderma (HP:0001029) | 1.76850336 |
| 139 | Aortic dissection (HP:0002647) | 1.76402843 |
| 140 | Abnormal foot bone ossification (HP:0010675) | 1.75573687 |
| 141 | Flat acetabular roof (HP:0003180) | 1.74939723 |
| 142 | Periodontitis (HP:0000704) | 1.74764449 |
| 143 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73778233 |
| 144 | Increased IgE level (HP:0003212) | 1.72637424 |
| 145 | Recurrent skin infections (HP:0001581) | 1.72595108 |
| 146 | High pitched voice (HP:0001620) | 1.72585423 |
| 147 | Autoimmune hemolytic anemia (HP:0001890) | 1.72437024 |
| 148 | Lymphoma (HP:0002665) | 1.70591654 |
| 149 | Mesomelia (HP:0003027) | 1.70167064 |
| 150 | Basal cell carcinoma (HP:0002671) | 1.69542283 |
| 151 | Abnormality of the radial head (HP:0003995) | 1.68885616 |
| 152 | Limited elbow extension (HP:0001377) | 1.68503996 |
| 153 | Chronic sinusitis (HP:0011109) | 1.68058923 |
| 154 | Ankle contracture (HP:0006466) | 1.67979381 |
| 155 | Ulnar bowing (HP:0003031) | 1.67698704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.30157109 |
| 2 | EEF2K | 3.54225992 |
| 3 | PRPF4B | 3.37226430 |
| 4 | TXK | 3.26090776 |
| 5 | JAK3 | 3.13826334 |
| 6 | STK10 | 2.54927409 |
| 7 | TRIB3 | 2.16092778 |
| 8 | ERN1 | 2.09335049 |
| 9 | ZAP70 | 2.08538074 |
| 10 | TYK2 | 2.07893637 |
| 11 | MAP3K14 | 2.06836809 |
| 12 | PKN2 | 2.05692359 |
| 13 | MAP3K10 | 2.00454557 |
| 14 | ITK | 1.95402567 |
| 15 | CDK12 | 1.87337981 |
| 16 | TBK1 | 1.85945582 |
| 17 | TTN | 1.79518928 |
| 18 | TEC | 1.77508187 |
| 19 | KIT | 1.73650155 |
| 20 | NME2 | 1.71013024 |
| 21 | RIPK4 | 1.70438547 |
| 22 | LRRK2 | 1.68885491 |
| 23 | GRK7 | 1.65719753 |
| 24 | FGFR4 | 1.63701824 |
| 25 | NLK | 1.61477750 |
| 26 | IKBKE | 1.58055976 |
| 27 | CDC42BPA | 1.57202356 |
| 28 | JAK1 | 1.51915402 |
| 29 | MAP3K13 | 1.51564166 |
| 30 | FGFR3 | 1.48878819 |
| 31 | MYLK | 1.44166797 |
| 32 | RPS6KA4 | 1.42886161 |
| 33 | BTK | 1.40611760 |
| 34 | TGFBR2 | 1.39418371 |
| 35 | PIM1 | 1.35118470 |
| 36 | MOS | 1.32866840 |
| 37 | HCK | 1.31954827 |
| 38 | EPHB1 | 1.30093862 |
| 39 | TAOK2 | 1.29850402 |
| 40 | PIM2 | 1.29633542 |
| 41 | PRKD2 | 1.27085501 |
| 42 | CSK | 1.26865154 |
| 43 | CDC7 | 1.25709865 |
| 44 | NEK2 | 1.24236824 |
| 45 | TGFBR1 | 1.23184997 |
| 46 | IKBKB | 1.21771776 |
| 47 | LCK | 1.18297732 |
| 48 | CDK6 | 1.17821770 |
| 49 | MAP2K3 | 1.16503256 |
| 50 | SIK1 | 1.15250264 |
| 51 | CDK4 | 1.12908316 |
| 52 | TRPM7 | 1.09781624 |
| 53 | ALK | 1.05087635 |
| 54 | STK38 | 1.02350859 |
| 55 | TESK2 | 1.01481150 |
| 56 | CDK9 | 1.00238551 |
| 57 | MARK2 | 0.98556760 |
| 58 | MST4 | 0.98415664 |
| 59 | CHUK | 0.97661760 |
| 60 | PIK3CG | 0.94715684 |
| 61 | SYK | 0.94698232 |
| 62 | PAK2 | 0.94104165 |
| 63 | RIPK1 | 0.92221506 |
| 64 | TSSK6 | 0.91874480 |
| 65 | MAPK7 | 0.91114972 |
| 66 | KDR | 0.90522989 |
| 67 | PTK6 | 0.89343817 |
| 68 | BMX | 0.89063272 |
| 69 | BLK | 0.88997537 |
| 70 | CLK1 | 0.88957903 |
| 71 | MAP3K3 | 0.86133931 |
| 72 | RPS6KB2 | 0.85958049 |
| 73 | TAOK3 | 0.82234841 |
| 74 | TAOK1 | 0.80687435 |
| 75 | GRK6 | 0.80405648 |
| 76 | PDGFRB | 0.80051952 |
| 77 | CAMK1D | 0.77957341 |
| 78 | NEK9 | 0.76788864 |
| 79 | EPHA3 | 0.75876420 |
| 80 | CSF1R | 0.75685457 |
| 81 | HIPK2 | 0.75069108 |
| 82 | MAP3K11 | 0.74249170 |
| 83 | BMPR2 | 0.74083498 |
| 84 | TESK1 | 0.73620965 |
| 85 | MAP3K8 | 0.73438227 |
| 86 | MAP3K1 | 0.73195381 |
| 87 | STK3 | 0.68476449 |
| 88 | IRAK4 | 0.67718861 |
| 89 | TYRO3 | 0.67222639 |
| 90 | PAK4 | 0.67055474 |
| 91 | SIK3 | 0.66564175 |
| 92 | JAK2 | 0.66080520 |
| 93 | MAP3K6 | 0.65080542 |
| 94 | ATR | 0.63990135 |
| 95 | MAPK12 | 0.63482504 |
| 96 | PRKCH | 0.62695390 |
| 97 | MATK | 0.62500091 |
| 98 | AKT3 | 0.59731193 |
| 99 | FLT3 | 0.58939859 |
| 100 | PASK | 0.58900481 |
| 101 | MAPK11 | 0.58847148 |
| 102 | PRKD3 | 0.58662516 |
| 103 | MTOR | 0.57956587 |
| 104 | SCYL2 | 0.56343968 |
| 105 | RPS6KA2 | 0.54943768 |
| 106 | PDPK1 | 0.53892698 |
| 107 | DMPK | 0.53681022 |
| 108 | FES | 0.50666548 |
| 109 | LYN | 0.49920534 |
| 110 | LIMK1 | 0.49572207 |
| 111 | TNK2 | 0.49526109 |
| 112 | PDGFRA | 0.49276458 |
| 113 | PRKCQ | 0.48764689 |
| 114 | IRAK1 | 0.48093488 |
| 115 | SIK2 | 0.47726032 |
| 116 | CAMK1G | 0.46941376 |
| 117 | PDK1 | 0.46623315 |
| 118 | CAMKK1 | 0.44331421 |
| 119 | KSR2 | 0.44125413 |
| 120 | PTK2 | 0.43127758 |
| 121 | FGR | 0.42995837 |
| 122 | EGFR | 0.42834328 |
| 123 | PRKG2 | 0.42373579 |
| 124 | ICK | 0.41845425 |
| 125 | IRAK3 | 0.41698571 |
| 126 | SGK3 | 0.41153289 |
| 127 | PRKD1 | 0.40821474 |
| 128 | DDR2 | 0.40571683 |
| 129 | MAP3K7 | 0.40024080 |
| 130 | ABL1 | 0.39669327 |
| 131 | MELK | 0.39613706 |
| 132 | AURKB | 0.38210556 |
| 133 | MARK3 | 0.38176574 |
| 134 | FGFR1 | 0.36845215 |
| 135 | MAPKAPK2 | 0.36538860 |
| 136 | RPS6KA6 | 0.35601841 |
| 137 | CHEK1 | 0.35231113 |
| 138 | INSR | 0.33628553 |
| 139 | PTK2B | 0.32917279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.55086809 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.54975882 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18396675 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.11092243 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.04745421 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.02314862 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98328859 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89586041 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86863664 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81476456 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71191759 |
| 12 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68380981 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67208916 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64877248 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63012820 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61577839 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54173868 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52279747 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51767078 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49262173 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46302966 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.40262619 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40214763 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.39833439 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.38636271 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38636023 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.38376909 |
| 28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.37067792 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35154989 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.32506524 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30502724 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.29923019 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29849975 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.29204509 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26678863 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26013413 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24918735 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23694072 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23582997 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.23480705 |
| 41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22795858 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 1.22165603 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20148416 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.17392901 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.14188151 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.14113160 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11550244 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10076066 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.08388202 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.08286401 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08037559 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07149801 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01122128 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 1.00510598 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 1.00467601 |
| 56 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97023658 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93820465 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91756674 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90755909 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90313672 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.89424616 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.87943270 |
| 63 | Cell cycle_Homo sapiens_hsa04110 | 0.87642613 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87189467 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87095734 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86858019 |
| 67 | Adherens junction_Homo sapiens_hsa04520 | 0.85716984 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.85540756 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85159604 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.84969042 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84690112 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82499120 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80823890 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.78278888 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75889021 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75429264 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74699573 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73994319 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.72961631 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.72947505 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72239071 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.71345394 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.70660479 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70115051 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69938556 |
| 86 | Mismatch repair_Homo sapiens_hsa03430 | 0.69667888 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67842489 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67744520 |
| 89 | RNA transport_Homo sapiens_hsa03013 | 0.66200571 |
| 90 | Spliceosome_Homo sapiens_hsa03040 | 0.66017702 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64642692 |
| 92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64470608 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.64191192 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.62872144 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62674775 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61921657 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.61458814 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61294177 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60940399 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58707108 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58293567 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57581131 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56808051 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55694664 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.55164427 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54529996 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54528848 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54499050 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54046500 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54039124 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53824225 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53727683 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52295420 |
| 114 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52183586 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51314180 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49922244 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48716986 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48415109 |
| 119 | Ribosome_Homo sapiens_hsa03010 | 0.47660783 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47659005 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46895582 |
| 122 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46816258 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45087202 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43934686 |

